Related Experiment Video
Updated: Aug 26, 2026

Closed-Loop Neurostimulation for Biomarker-Driven, Personalized Treatment of Major Depressive Disorder
Published on: July 7, 2023
Treatment of bipolar depression
Robert M Post1, Claudia F Baldassano, Roy H Perlis
1Bipolar Collaborative Network, Chevy Chase, Maryland, USA.
Abstract:
Bipolar disorder is underdiagnosed and often mistaken for unipolar depression. Bipolar patients spend 33% of their time in a state of depression compared to 11% of time spent in a manic state. Duration of time depressed and severity of depression are associated with increased risk for suicide, which occurs in 10% to 20% of bipolar patients. Antidepressants are increasingly being used as adjuncts in the depressed phase of bipolar disorder, although they provide a moderate risk for switch into mania. Lithium and some antiepileptics and atypical antipsychotics have shown antidepressant effects in the treatment of bipolar disorder. Other adjuncts for treatment-refractory patients include monoamine oxidase inhibitors and electroconvulsive therapy.
Related Concept Videos
Mania and Antimanic Drugs: Overview
Bipolar Disorder
Antidepressant Drugs: MAOIs and Other Agents
Psychosis: Goals of Pharmacotherapy
Electroconvulsive Therapy
Drug Therapy
Antianxiety Medications